Prof John Cleland (University of Glasgow & Glasgow Royal Infirmary, Glasgow, UK) joined us to talk about heart failure management highlights in 2022 including a new phenotype, HFsnEF; available and new treatment options; news on SGLT2is and more.
Recorded at Heart Failure 2022, Madrid.
Videographer: Tom Green
Editor: Mirjam Boros